Presenilin Enhancer 2 (PEN-2) Protein
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Presenilin Enhancer 2 (PEN-2)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td><a href="/genes/psenen">PSENEN</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9NQ75" target="_blank">Q9NQ75</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td><a href="https://www.rcsb.org/structure/5A63" target="_blank">5A63</a>, <a href="https://www.rcsb.org/structure/6IDF" target="_blank">6IDF</a></td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>~10 kDa (101 aa, two transmembrane domains)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Endoplasmic reticulum, Golgi apparatus, plasma membrane</td>
</tr>
<tr>
<td class="label">Family</td>
<td>PEN-2 family ([γ-secretase](/entities/gamma-secretase) complex)</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td><a href="/diseases/alzheimers">Alzheimer's Disease</a>, <a href="/diseases/ftd">Frontotemporal Dementia</a></td>
</tr>
</table>
Presenilin Enhancer 2 (PEN-2)
Introduction
Presenilin Enhancer 2 (Pen 2) Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...Presenilin Enhancer 2 (PEN-2) Protein
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Presenilin Enhancer 2 (PEN-2)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td><a href="/genes/psenen">PSENEN</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9NQ75" target="_blank">Q9NQ75</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td><a href="https://www.rcsb.org/structure/5A63" target="_blank">5A63</a>, <a href="https://www.rcsb.org/structure/6IDF" target="_blank">6IDF</a></td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>~10 kDa (101 aa, two transmembrane domains)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Endoplasmic reticulum, Golgi apparatus, plasma membrane</td>
</tr>
<tr>
<td class="label">Family</td>
<td>PEN-2 family ([γ-secretase](/entities/gamma-secretase) complex)</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td><a href="/diseases/alzheimers">Alzheimer's Disease</a>, <a href="/diseases/ftd">Frontotemporal Dementia</a></td>
</tr>
</table>
Presenilin Enhancer 2 (PEN-2)
Introduction
Presenilin Enhancer 2 (Pen 2) Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
Presenilin Enhancer 2 (PEN-2) is the smallest and final subunit to join the gamma-secretase complex, which also includes presenilin ([PSEN1](/entities/psen1)/PSEN2), nicastrin (NCT), and APH-1[@steiner2008]. Despite its small size, PEN-2 is essential for gamma-secretase activity - it serves as the enzymatic component that directly contributes to the aspartyl protease activity of the complex. PEN-2 was originally identified in a genetic screen in C. elegans as an enhancer of presenilin mutants, giving it its name["@edbauer2003"].
PEN-2 is a unique membrane protein with only two transmembrane domains, forming a hairpin structure that inserts into the membrane. It is required for the endoproteolysis of presenilin and for the stabilization of the active gamma-secretase complex["@prokop2005"].
Structure
PEN-2 is a 101-amino acid protein with a distinctive hairpin topology:
Two Transmembrane Domains
- TMD1: residues 18-40
- TMD2: residues 54-76
- Short extracellular/luminal loops connecting the TMDs
Key Structural Features
- Hairpin structure with both termini in the cytoplasm
- Highly conserved across species
- Forms tight complexes with presenilin
- Contains a DAP (Asp-Ala-Pro) sequence important for function
Normal Function
γ-Secretase Assembly and Activation
PEN-2 plays multiple critical roles:
1. Presenilin Endoproteolysis
- PEN-2 is required for the autocatalytic cleavage of presenilin
- Without PEN-9, presenilin remains as a full-length holoenzyme
- Cleavage produces the N-terminal and C-terminal fragments (NTF/CTF)
2. Catalytic Component
- Provides the second aspartate residue for the active site
- The DAP motif (Asp-Ala-Pro) in TMD2 contains critical aspartate
- Forms the catalytic aspartyl protease with presenilin
3. Complex Stabilization
- PEN-2 stabilizes the assembled complex
- Prevents degradation of individual subunits
- Facilitates proper trafficking
Substrate Processing
The γ-secretase complex processes numerous type I transmembrane proteins:
- [Amyloid precursor protein](/entities/app-protein) (APP)
- Notch receptors
- E-cadherin
- Synaptic adhesion molecules
- Cytokine receptors
Role in Disease
Alzheimer's Disease
Aβ Generation
PEN-2 directly affects amyloid-β production:
- Modulates γ-secretase activity
- Influences [Aβ42](/proteins/amyloid-beta)/Aβ40 ratio
- Impacted by disease-causing mutations
Mutations
- PSENEN mutations are linked to early-onset familial Alzheimer's disease
- Mutations can increase Aβ42/Aβ40 ratio
- Some mutations cause loss of function
γ-Secretase Inhibitors
Understanding PEN-2's role has informed drug development:
- Targeting the interface between PEN-2 and presenilin
- Allosteric modulators
- Subunit-specific inhibitors
Cancer
γ-secretase and thus PEN-2:
- Regulates Notch signaling in tumor cells
- Affects cell proliferation and differentiation
- Potential therapeutic target
γ-Secretase Complex Assembly
The sequential assembly of γ-secretase follows a specific order:
PEN-2 is the final subunit added and is essential for converting the precursor complex into an active enzyme.
Key Publications
[Steiner H et al., PEN-2 is essential for γ-secretase (2002)](https://doi.org/10.1074/jbc.M205592200)
[Edbauer D et al., Reconstitution of γ-secretase (2003)](https://doi.org/10.1073/pnas.0534348100)
[Crystal AS et al., γ-Secretase subunits (2003)](https://doi.org/10.1074/jbc.M310352200)
[Walters A & Koo EH, γ-Secretase in AD (2011)](https://doi.org/10.1038/nm0211-233)
[De Strooper B et al., γ-Secretase function (2012)](https://doi.org/10.1101/cshperspect.a006304)
Background
The study of Presenilin Enhancer 2 (Pen 2) Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Cross-References
- [PSENEN Gene](/genes/psenen)
- [Presenilin-1 Protein](/proteins/presenilin-1)
- [Presenilin-2 Protein](/proteins/presenilin-2)
- [Nicastrin Protein](/proteins/nicastrin)
- [APH-1 Protein](/proteins/aph-1)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Gamma-Secretase in AD](/mechanisms/gamma-secretase)
- [Amyloid-Beta Protein](/proteins/amyloid-beta-protein)
See Also
- [Proteins Index](/proteins/)
- [Genes Index](/genes/)
- [Diseases Index](/diseases/)
References
[Steiner H, Fluhrer R, Haass C, Gamma-secretase: a multidisciplinary target for the treatment of Alzheimer's disease (2008)](https://doi.org/10.1074/jbc.R800010200)
[Edbauer D, Winkler E, Regula JT, et al, Reconstitution of gamma-secretase activity (2003)](https://doi.org/10.1038/ncb983)
[Prokop S, Haass C, Steiner H, Structure and function of γ-secretase (2005)](https://doi.org/10.1038/nrn1733)Pathway Diagram
The following diagram shows the key molecular relationships involving Presenilin Enhancer 2 (PEN-2) Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)